PATENT CLAIM ANALYSIS

Application Number: 15967627
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "254020"]

Abstract:
A method for determining the risk of cardiovascular disease in a subject having a chronic viral infection includes determining a level of determining a level of at least one lysophophatidic acid (LPA) subtype in the subject, wherein the LPA subtype is selected from the group consisting of LPA 16:0, 18:1, 18:2, and 20:4 and comparing the determined level of the at least one LPA to a control level, wherein an increased level of at least one LPA subtype is indicative of the subject having an increased risk of cardiovascular disease associated with the chronic viral infection.

Claim (Index 10):
The method of  claim 1 , the chronic viral infection selected from the group consisting of HIV, HCV and HIV/HCV co-infection.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 93.0
- Lexical Diversity: 2.12245
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14460895', '12739639', '15510315', '12626848', '13583031']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7537748543686837
- 35 USC 102 Novelty (BERT): 0.6866223952723328
- Combined Prediction Score: 0.7470596084590486
- Mean Citation Score: 376.966008
- Max Citation Score: 703.35205
- Similarity Product: 670.3645215142875

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test